Cost-effectiveness of GeneXpert Omni compared with GeneXpert MTB/Rif for point-of-care diagnosis of tuberculosis in a low-resource, high-burden setting in Eastern Uganda: a cost-effectiveness analysis based on decision analytical modelling.

David Livingstone EjaluAaron IriokoRhoda KiraboAggrey David MukoseElizabeth EkirapaJoseph KagaayiJuliana Namutundu

Published in: BMJ open (2022)

The use of Xpert Omni at the point-of-care health facility was more effective but with an increased cost compared with Xpert MTB/Rif at the centralised referral testing facility.

Keyphrases

pulmonary tuberculosis
mycobacterium tuberculosis
long term care
healthcare
public health
primary care
mental health
south africa
emergency department
health information
decision making
risk factors
risk assessment
climate change
human immunodeficiency virus
electronic health record
drug induced
data analysis